AFC
BIIB icon

Ares Financial Consulting’s Biogen BIIB Stock Holding History

Ares Financial Consulting’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6K Hold
123
– – 0.02% 353
2026
Q1 		$22.6K Buy
123
+98
+392% +$18.1K 0.02% 366
2025
Q4 		$4.4K Buy
+25
New +$4.08K ﹤0.01% 510

Other funds holding BIIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ares Financial Consulting's BIIB Position: Q2 2026 in Review

Ares Financial Consulting held its Biogen (BIIB) position steady in Q2 2026 at 123 shares worth $26.6K. The position accounts for 0.02% of the portfolio, ranked #353.

Ares Financial Consulting first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 510 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Ares Financial Consulting held 123 shares of Biogen worth $26.6K as of Q2 2026.
  • Ares Financial Consulting left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of Ares Financial Consulting's portfolio in Q2 2026, its #353 holding.
  • Ares Financial Consulting first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 510 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.